Martin Bengtsson
Papers
1
Total Citations
31
H-Index
1
About
Martin Bengtsson is a leading figure in bioanalytical chemistry, with a primary research focus on developing innovative mass spectrometry-based workflows for clinical diagnostics and proteomics. His major contributions center on integrating immunoaffinity capture with advanced sample preparation and MALDI-TOF MS analysis. In his highly cited 2011 work (31 citations), Bengtsson pioneered a noncovalent antibody immobilization strategy on porous silicon, ingeniously combining this with miniaturized solid-phase extraction (SPE) on a reverse-phase integrated sample enrichment target (RP-ISET). This approach, termed ImmunoMALDI, enables rapid, sensitive, and multiplexed detection of target proteins directly from complex biological samples, such as serum or plasma, without extensive pre-processing. By merging the specificity of antibodies with the high-throughput speed of MALDI MS, his work has significantly advanced the field of targeted proteomics, offering a powerful tool for biomarker verification and clinical assays. Bengtsson’s research continues to bridge the gap between fundamental analytical chemistry and practical biomedical applications, making him a key innovator in the development of next-generation diagnostic platforms.
Research Focus
Key Achievements
Top Papers
- 1